Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituxan in Newly Diagnosed Multiple Myeloma
NCT00003554Phase 2Completed
- Sponsor
- Cleveland Clinic
- Start
- Nov 1998
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in multiple myeloma (MM), sponsored by Cleveland Clinic. Started Nov 1998; status: completed.
02
Drugs
rituximab
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00003554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003554.